Femme et Homme
- | Pays :
- France
- United States
- | Organes : -
- | Spécialités : -
Extrait
This is a multicenter, open-label study to evaluate the safety and efficacy of treatment with brentuximab vedotin (SGN-35) in patients who have previously participated in an brentuximab vedotin study.
Critère d'inclusion
- Disease, Hodgkin ,Lymphoma, Large-Cell, Anaplastic ,Lymphoma. Non-Hodgkin